The Cigna Group
CI
$278.35
$0.150.05%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 267.09B | 261.19B | 254.45B | 246.15B | 231.60B |
| Total Other Revenue | 984.00M | 836.00M | 921.00M | 973.00M | 986.00M |
| Total Revenue | 268.08B | 262.02B | 255.37B | 247.12B | 232.59B |
| Cost of Revenue | 242.47B | 236.19B | 229.18B | 221.16B | 206.51B |
| Gross Profit | 25.61B | 25.83B | 26.19B | 25.96B | 26.08B |
| SG&A Expenses | 13.96B | 14.33B | 14.68B | 14.55B | 14.55B |
| Depreciation & Amortization | 1.70B | 1.70B | 1.70B | 1.70B | 1.73B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 258.14B | 252.22B | 245.56B | 237.41B | 222.79B |
| Operating Income | 9.94B | 9.80B | 9.81B | 9.72B | 9.79B |
| Income Before Tax | 7.97B | 6.87B | 6.84B | 5.27B | 3.45B |
| Income Tax Expenses | 1.42B | 1.47B | 1.44B | 1.49B | 99.00M |
| Earnings from Continuing Operations | 6.55K | 5.40K | 5.40K | 3.78K | 3.35K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -403.00M | -384.00M | -365.00M | -344.00M | -310.00M |
| Net Income | 6.15B | 5.02B | 5.03B | 3.43B | 3.04B |
| EBIT | 9.94B | 9.80B | 9.81B | 9.72B | 9.79B |
| EBITDA | 12.64B | 12.45B | 12.52B | 12.49B | 12.69B |
| EPS Basic | 22.79 | 18.42 | 18.17 | 12.32 | 10.69 |
| Normalized Basic EPS | 18.22 | 17.67 | 17.42 | 17.15 | 17.19 |
| EPS Diluted | 22.66 | 18.31 | 18.05 | 12.23 | 10.60 |
| Normalized Diluted EPS | 18.12 | 17.55 | 17.30 | 17.05 | 17.09 |
| Average Basic Shares Outstanding | 1.08B | 1.09B | 1.11B | 1.12B | 1.14B |
| Average Diluted Shares Outstanding | 1.09B | 1.10B | 1.12B | 1.13B | 1.15B |
| Dividend Per Share | 5.93 | 5.82 | 5.71 | 5.60 | 5.43 |
| Payout Ratio | 26.01% | 31.63% | 31.35% | 45.63% | 50.71% |